Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
Preeclampsia is one of the most serious complications of pregnancy. Currently there are no medical treatments. Given placental oxidative stress may be an early trigger in the pathogenesis of preeclampsia, therapies that enhance antioxidant pathways have been proposed as treatments. Melatonin is a di...
Hoofdauteurs: | Natalie J Hannan, Natalie K Binder, Sally Beard, Tuong-Vi Nguyen, Tu'uhevaha J Kaitu'u-Lino, Stephen Tong |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Public Library of Science (PLoS)
2018-01-01
|
Reeks: | PLoS ONE |
Online toegang: | http://europepmc.org/articles/PMC5894956?pdf=render |
Gelijkaardige items
-
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
door: Natalie J. Hannan, et al.
Gepubliceerd in: (2017-05-01) -
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
door: Tu'uhevaha J Kaitu'u-Lino, et al.
Gepubliceerd in: (2018-01-01) -
Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
door: Roxanne Hastie, et al.
Gepubliceerd in: (2022-08-01) -
Placental galectin-3 is reduced in early-onset preeclampsia
door: Manju Kandel, et al.
Gepubliceerd in: (2022-10-01) -
Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
door: Stephen Tong, et al.
Gepubliceerd in: (2021-01-01)